What is the treatment for paracetamol (acetaminophen) poisoning?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Paracetamol (Acetaminophen) Poisoning

Immediate Management: N-Acetylcysteine (NAC) is the Cornerstone

Administer N-acetylcysteine immediately to all patients with suspected or confirmed paracetamol poisoning when serum levels plot above the "possible toxicity" line on the Rumack-Matthew nomogram, when timing is unknown, or when hepatotoxicity is already present—ideally within 8 hours of ingestion to maximize efficacy. 1

Critical Time Windows for NAC Efficacy

The effectiveness of NAC is dramatically time-dependent:

  • 0-8 hours post-ingestion: Only 2.9% develop severe hepatotoxicity when treated within this window 1
  • 8-10 hours: Risk increases to 6.1% 1
  • 10-24 hours: Risk jumps to 26.4% 1
  • Beyond 24 hours: NAC still provides benefit and reduces mortality, though efficacy is significantly diminished 1

Never withhold NAC even in late presentations (>24 hours), as it reduces mortality from 80% to 52% in fulminant hepatic failure regardless of time since ingestion. 1

Initial Assessment and Risk Stratification

Laboratory Evaluation (Obtain Immediately)

  • Serum paracetamol level (must be drawn ≥4 hours post-ingestion for accurate nomogram interpretation) 2
  • Liver function tests: AST, ALT, alkaline phosphatase, total bilirubin 3, 2
  • Coagulation studies: INR/prothrombin time 3, 2
  • Renal function: Creatinine, BUN 2
  • Metabolic panel: Glucose, electrolytes, arterial lactate 3
  • Arterial blood gas 3

Using the Rumack-Matthew Nomogram

The nomogram applies ONLY to single acute ingestions with known time of ingestion when levels are drawn 4-24 hours post-ingestion. 1, 2

  • Plot the paracetamol concentration against time post-ingestion 1
  • Treatment line: Starts at 150 mg/L (992 µmol/L) at 4 hours, extending to 24 hours with a half-life of 4 hours 4
  • Treat all patients at or above the "possible toxicity" line 1, 2

Critical pitfall: The nomogram does NOT apply to repeated supratherapeutic ingestions, extended-release formulations, or presentations >24 hours post-ingestion 1

NAC Dosing Regimens

Intravenous Protocol (Preferred in Most Settings)

Two-bag regimen (current recommendation): 5

  • First dose: 200 mg/kg in 5% dextrose over 4 hours
  • Second dose: 100 mg/kg over 16 hours (total 20-hour protocol)

Traditional three-bag regimen: 1, 2

  • Loading dose: 150 mg/kg over 15 minutes (or more slowly over 1-2 hours to reduce anaphylactoid reactions)
  • Second dose: 50 mg/kg over 4 hours
  • Third dose: 100 mg/kg over 16 hours (total 21-hour protocol)

Oral Protocol (Alternative)

  • Loading dose: 140 mg/kg by mouth or nasogastric tube 1
  • Maintenance: 70 mg/kg every 4 hours for 17 additional doses (total 72 hours) 1

The oral regimen may be superior when treatment is delayed and is as effective as IV NAC. 1

Activated Charcoal

Give activated charcoal (1 g/kg orally) just prior to starting NAC if the patient presents within 4 hours of ingestion. 1, 2

  • Most effective within 1-2 hours but may provide benefit up to 4 hours 1
  • Ensure airway protection, especially with co-ingestions 1

Special Clinical Scenarios

Unknown Time of Ingestion

Start NAC loading dose immediately without waiting for laboratory results. 1, 2

  • Obtain paracetamol level to guide continuation of therapy 2
  • Treat if any detectable paracetamol level is present 1

Delayed Presentation (>24 Hours Post-Ingestion)

Administer NAC immediately based on clinical presentation and laboratory findings rather than nomogram placement. 1

  • The nomogram is invalid in this timeframe 1
  • Base treatment decisions on paracetamol levels, transaminases, and INR 1
  • Continue NAC until transaminases are declining and INR normalizes 1

Established Hepatotoxicity or Fulminant Hepatic Failure

All patients with acute liver failure suspected to be from paracetamol must receive NAC immediately, regardless of time since ingestion (Level B recommendation). 1

  • NAC reduces mortality from 80% to 52% 1
  • Reduces cerebral edema from 68% to 40% 1
  • Reduces need for inotropic support from 80% to 48% 1
  • Contact liver transplant center immediately 3
  • Requires ICU-level care 1, 3

Repeated Supratherapeutic Ingestions (RSTI)

Treat with NAC if: 1

  • ≥10 g or 200 mg/kg (whichever is less) during a single 24-hour period, OR
  • ≥6 g or 150 mg/kg (whichever is less) per 24-hour period for ≥48 hours, OR
  • Serum paracetamol ≥10 mg/mL, OR
  • AST or ALT >50 IU/L

The nomogram does not apply to RSTI—use clinical judgment and laboratory values. 1

Extended-Release Paracetamol

Obtain two paracetamol levels: 1, 2

  • First at 4 hours post-ingestion
  • Second at 8-10 hours post-ingestion

Treat with full NAC course if either level is at or above the treatment line. 2

Massive Overdoses

For paracetamol concentrations more than double the nomogram line, increase NAC dosing beyond standard protocol. 1, 5

  • Consider step-wise increases at the 300-, 450-, and 600-lines on the nomogram 1
  • Patients ingesting ≥30 g or ≥500 mg/kg should receive increased doses 5

High-Risk Populations (Lower Treatment Threshold)

Treat even with paracetamol levels in the "non-toxic" range for: 1

  • Chronic alcohol consumption: Severe hepatotoxicity documented with doses as low as 4-5 g/day 1, 6
  • Malnutrition or fasting states 1
  • Pre-existing liver disease 6, 3
  • CYP2E1 enzyme-inducing drugs (e.g., isoniazid) 2

Criteria for Stopping NAC

NAC can be discontinued when ALL of the following criteria are met: 1

  • Paracetamol level is undetectable
  • AST and ALT are normal or declining
  • INR is normal
  • Patient is asymptomatic

Red flags that mandate continuing or restarting NAC: 1

  • Any elevation in AST or ALT above normal
  • Rising transaminases
  • Any coagulopathy (elevated INR)
  • Detectable paracetamol level
  • Clinical signs of hepatotoxicity

For delayed presentations, extended-release formulations, RSTI, or unknown timing, continue NAC beyond the standard protocol until criteria above are met. 1

Critical Warning Signs Requiring Immediate Escalation

Very high aminotransferases (AST/ALT >3,500 IU/L) are highly correlated with paracetamol poisoning even without clear overdose history. 6, 3

Immediate ICU transfer and transplant hepatology consultation if: 1, 3

  • AST/ALT >1,000 IU/L
  • Coagulopathy (elevated INR)
  • Altered mental status or hepatic encephalopathy
  • Hypoglycemia
  • Elevated arterial lactate
  • Renal dysfunction

Clinical Presentation Timeline

Understanding the temporal progression helps guide management:

  • 0-24 hours: Nonspecific symptoms (nausea, vomiting, malaise); may be asymptomatic 3
  • 24-72 hours: Liver enzymes begin rising; jaundice may appear; right upper quadrant tenderness variably present 3
  • 72-96 hours: Maximum liver damage; AST/ALT potentially in thousands; coagulopathy develops 3

Early recognition is critical as liver damage may not be apparent until 24-72 hours post-ingestion. 3

Common Pitfalls to Avoid

  • Do not wait for paracetamol levels if presentation is >8 hours post-ingestion—start NAC immediately 1, 2
  • Low or absent paracetamol levels do not rule out poisoning if ingestion was remote or occurred over several days 1, 6
  • Do not rely on patient-reported ingestion quantity—it is often inaccurate 2
  • Do not use the nomogram for RSTI, extended-release formulations, or presentations >24 hours 1
  • Even therapeutic doses (4 g/day for 14 days) can cause ALT elevations >3× normal in 31-41% of healthy adults 6

References

Guideline

Acetaminophen Overdose Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Paracetamol Poisoning Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Acetaminophen Toxicity Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.